NCT01032902View on ClinicalTrials.gov

Evaluation of the Performance of Chembio Diagnostics Systems, Inc. DPP® HIV 1/2 Rapid Test

CompletedOBSERVATIONAL
Enrollment

2,808

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

April 30, 2012

Study Completion Date

April 30, 2012

Conditions
HIV Infections
Interventions
DEVICE

In Vitro Diagnostic Device

For the detection of antibodies to HIV in serum, plasma, blood and oral fluid

Trial Locations (5)

19102

St. Christopher's Hospital for Children/ Drexel University College of Medicine, Philadelphia

33308

Therafirst, Fort Lauderdale

77030

University of Texas HSC, Houston

92093

Univeristy of California, San Diego, La Jolla

21201-1559

University of Maryland, Baltimore

Sponsors
All Listed Sponsors
lead

Chembio Diagnostic Systems, Inc.

INDUSTRY

NCT01032902 - Evaluation of the Performance of Chembio Diagnostics Systems, Inc. DPP® HIV 1/2 Rapid Test | Biotech Hunter | Biotech Hunter